Skip to main content

Sleep Problems in ADHD - Neurophysiological Correlates

Sleep Problems in ADHD - Neurophysiological Correlates

Last updated:

Sleep problems in 5- to 13-year-olds with ADHD were weakly but statistically significantly correlated with their mothers’ mental health problems.1

For more information on sleep problems, click here:

1. Neurotransmitters and Sleep-Wake Regulation

Numerous neurotransmitters are involved in the brain’s sleep-wake regulation.

  • Serotonin2345
  • Norepinephrine26
    • Administration of norepinephrine into the ventromedial hypothalamus of lean, insulin-sensitive animals—which raised norepinephrine levels there to those of obese, insulin-resistant animals—led within a few days to the full-blown cardiometabolic syndrome (including leptin resistance), while food intake remained unchanged. An additional administration of serotonin enhanced this norepinephrine response.7
  • Histamine6
  • Acetylcholine86
  • GABA94
  • Glutamate6
  • Dopamine1011
    • Abnormalities in dopamine metabolism and dopamine receptors are also involved in excessive daytime sleepiness (e.g., narcolepsy)12
    • Selective dopamine reuptake inhibitors promote wakefulness more effectively than selective norepinephrine reuptake inhibitors in both normal and narcoleptic animals13
    • Severe sleep disorders frequently occur in people with Parkinson’s disease or Huntington’s disease, who have dopaminergic dysfunction1415
    • Sleep disorders are associated with ADHD16
    • DAT gene variants appear to predispose humans to sleep-wake disorders10
    • Dopamine and melatonin play a role in regulating fatigue and sleep.
      The dopaminergic system is influenced by the circadian system.1718
      Dopamine is produced rhythmically in the amacrine cells of the retina. The retina is regulated by dopamine in the same way as it is by melatonin. The retina transmits light information to the suprachiasmatic nucleus, which serves as the body’s master biological clock. The suprachiasmatic nucleus sends timing information to regulate the rhythmic activity of dopaminergic brain regions and the behaviors controlled by them (locomotion, motivation). The dopamine produced in the substantia nigra and the ventral tegmental area may be rhythmically regulated by the suprachiasmatic nucleus via various neural pathways (including the orexin system or the medial preoptic nucleus of the hypothalamus).19 Orexin deficiency is a possible cause of narcolepsy. Orexin / Hypocretin Light exposure to the retina influences the circadian rhythm. Changes in light and light patterns can disrupt the circadian rhythm.20
      Dopamine and melatonin inhibit each other.21
      Dopamine is released primarily in the early morning and during the day. Melatonin is suppressed by daylight and is released mainly in the evening and at night.22
      Reduced extracellular dopamine (as is typical in ADHD) could therefore result in insufficient inhibition of melatonin. This might help explain the severe daytime sleepiness reported by some people with ADHD.
      The discussion focuses on whether retinal disorders cause the shifts in circadian rhythms commonly seen in ADHD and whether these could be a major cause of ADHD.23

1.1. Norepinephrine and the circadian rhythm

Norepinephrine is believed to be a key synchronizer of the circadian rhythm. Norepinephrine regulates nighttime melatonin release as well as circadian gene expression.2425

At the same time, prolonged sleep deprivation appears to cause lasting damage to the locus coeruleus, which would result in permanent damage to the noradrenergic system.26

1.2. Stress Systems and the Circadian Rhythm

Chronic stress (which, in our view, manifests its symptoms through neurotransmitter shifts very similar to those seen in ADHD) often leads to a disorder of the circadian system. For more on this, see Changes in the circadian system caused by chronic stress In the article Damage caused by early-onset or prolonged stress in the section ADHD as a chronic stress regulation disorder in the chapter Stress.

1.3. Dopamine and the Circadian Rhythm

Dopamine release follows a circadian rhythm. For more on this, see Dopaminergic circadian and ultradian rhythms In the article “ ” (The 6 dopaminergic Systems of the Brain) in the subsection “ ” (Dopamine) in the section “ ” (Neurotransmitters in ADHD) in the chapter “ ” (Neurological Aspects).

2. Cytokines and Sleep Problems

Sleep problems are associated with elevated levels of proinflammatory cytokines. Cytokines regulate sleep. Cytokines released by immune cells, particularly interleukin-1β and tumor necrosis factor-α, influence neuronal activity, behavior (including sleep), hormone release, and autonomic function by acting on neuroendocrine, autonomic, limbic, and cortical regions of the central nervous system.27 One study found elevated inflammatory markers only in women (not in men) with sleep problems.28

Sleep deprivation and disrupted sleep lead to elevated levels of IL-6, tumor necrosis factor (TNF) (in men only), and C-reactive protein (CRP) compared to periods of undisturbed sleep.293031
Sleep problems appear to increase IL-6 and soluble intercellular adhesion molecule (slCAM) even more than severe depression.32
Sleep deprivation correlates with elevated IL-6 levels, even though the stimulatory effect of catecholamines on IL-6 secretion is reduced; this change may result from the concurrent reduction in cortisol-induced inhibition, which is absent due to low cortisol levels. The stress hormones norepinephrine and CRH also increase IL-6.33

3. Other Substances Involved in Sleep-Wake Regulation

  • Melatonin
    For more information, visit Melatonin for ADHD In the subsection ⇒ Sleep-disorder-related medications for ADHD in the section Medications for ADHD – Overview / Appropriate Medications for ADHD in the chapter ⇒ Treatment
  • GHRH promotes sleep3435
    • The D1 receptor in the bovine hypothalamus mediated a 50% reduction in hypothalamic GHRH release in vitro36
  • Orexin (hypocretin)6
    • Neuropeptide
  • Adenosine35
    • Nucleoside
    • Blocks the release of excitatory neurotransmitters, e.g.:
      • Norepinephrine
      • Dopamine
      • Acetylcholine
  • Pro-inflammatory cytokines35
  • Prostaglandin D235
  • CRH inhibits sleep34 and disrupts deep sleep.37 Sleep problems could therefore be a direct consequence of an overactive HPA axis.

4. EEG Characteristics During Sleep in ADHD

There are reports of specific EEG abnormalities associated with ADHD.38
ADHD was associated with a significantly reduced micro-state D in the resting-state EEG and a lower probability of transitioning from micro-state C to D. However, this was independent of sleep problems.39

4.1. Sleep spindles

While more sleep spindles (higher sigma power) in the EEG of non-affected individuals during light sleep (sleep stage 2) correlated with a higher IQ, fewer sleep spindles correlated with ADHD.40

In contrast, another study found increased amplitude, duration, density, and activity of slow-wave spindles in children with ADHD.41

4.2. Gamma Connectivity During Light Sleep Is Altered in ADHD

Children with ADHD showed an altered gamma phase delay index during light sleep.42

4.3. Reduced slow-wave activity on the EEG during deep non-REM sleep in ADHD

People with ADHD-HI showed a reduction of more than 20% in EEG power of low-frequency waves ranging from 1 to 4.5 Hz (SWA) across the entire brain during deep non-REM sleep compared to healthy controls. Regular use of stimulants eliminated this difference. Assuming that SWA reflects synaptic density, this finding is consistent with previous neuroimaging studies that found smaller volumes of gray matter in people with ADHD-HI, as well as the normalization of these volumes with regular stimulant use.43

5. Immunological Consequences of Sleep Problems

Both acute and chronic sleep fragmentation increased the mRNA and protein levels of cytokines in the body tissues of mice. Changes in inflammatory responses reflected the activation of stress axes, with elevated levels of corticosterone and norepinephrine. Treatment with 6-OHDA significantly reduced the inflammation caused by sleep fragmentation. This suggests that the autonomic nervous system (sympathetic/parasympathetic) regulates sleep-fragmentation-induced inflammation in body tissues.
Chronic sleep fragmentation had more serious consequences than one-time (acute) sleep fragmentation. A one-week recovery period following sleep fragmentation sufficiently alleviated peripheral inflammatory responses, but not noradrenergic responses.44

6. Body Temperature and Sleep


  1. Martin, Papadopoulos, Rinehart, Sciberras (2019): Associations Between Child Sleep Problems and Maternal Mental Health in Children with ADHD. Behav Sleep Med. 2019 Nov 25:1-14. doi: 10.1080/15402002.2019.1696346.

  2. Steriade, McCarley (1990): Brainstem control of wakefulness and sleep, S. 185

  3. Roehrs, Carskadon, Dement, Roth (2000): Daytime Sleepiness and Alertness. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 42

  4. Jones (2000): Basic mechanisms of sleep–wake states In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 134

  5. McGinty, Ronald (2000): Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 64

  6. McGinty, Ronald (2000): Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 65

  7. Cincotta AH (2023): Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects. Int J Mol Sci. 2023 Aug 26;24(17):13255. doi: 10.3390/ijms241713255. PMID: 37686060; PMCID: PMC10487918. REVIEW

  8. Steriade, McCarley (1990): Brainstem control of wakefulness and sleep, S. 164

  9. Steriade, McCarley (1990): Brainstem control of wakefulness and sleep

  10. Wisor, Nishino, Sora, Uhl, Mignot, Edgar (2001): Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 2001 Mar 1;21(5):1787-94. doi: 10.1523/JNEUROSCI.21-05-01787.2001. PMID: 11222668; PMCID: PMC6762940.

  11. McGinty, Ronald (2000):Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 65

  12. Nishino, Mignot (1997): Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol. 1997 May;52(1):27-78. doi: 10.1016/s0301-0082(96)00070-6. PMID: 9185233. REVIEW

  13. Nishino, Mao, Sampathkumaran, Shelton (1998): Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online. 1998;1(1):49-61. PMID: 11382857.

  14. Zhang, Ren, Yang, Zhou, Li, Shi, Lu, Sanford, Tang (2019). Sleep in Huntington’s disease: a systematic review and meta-analysis of polysomongraphic findings. Sleep. 2019 Oct 9;42(10):zsz154. doi: 10.1093/sleep/zsz154. PMID: 31328779; PMCID: PMC6783889. METASTUDIE

  15. Wiegand, Möller, Lauer, Stolz, Schreiber, Dose, Krieg (1991): Nocturnal sleep in Huntington’s disease. J Neurol. 1991 Jul;238(4):203-8. doi: 10.1007/BF00314781. PMID: 1832711.

  16. Corkum, Moldofsky, Hogg-Johnson, Humphries, Tannock (1999): Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication. J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1285-93. doi: 10.1097/00004583-199910000-00018. PMID: 10517062.

  17. Parekh, Ozburn, McClung (2015): Circadian clock genes: effects on dopamine, reward and addiction. Alcohol. 2015 Jun;49(4):341-9. doi: 10.1016/j.alcohol.2014.09.034.

  18. Baltazar, Coolen, Webb (2013): Diurnal rhythms in neural activation in the mesolimbic reward system: critical role of the medial prefrontal cortex. Eur J Neurosci. 2013 Jul;38(2):2319-27. doi: 10.1111/ejn.12224.

  19. Mendoza, Challet (2014): Circadian insights into dopamine mechanisms. Neuroscience. 2014 Dec 12;282:230-42. doi: 10.1016/j.neuroscience.2014.07.081.

  20. Wirz-Justice, Wever, Aschoff (2004): Seasonality in freerunning circadian rhythms in man. Naturwissenschaften. 1984 Jun;71(6):316-9.

  21. Green, Besharse (2004): Retinal circadian clocks and control of retinal physiology. J Biol Rhythms. 2004 Apr;19(2):91-102.

  22. Iuvone, Tosini, Pozdeyev, Haque, Klein, Chaurasia (2005): Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. Prog Retin Eye Res. 2005 Jul;24(4):433-56.

  23. Bijlenga, Vollebregt, Kooij, Arns (2019): The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD? Atten Defic Hyperact Disord. 2019 Mar;11(1):5-19. doi: 10.1007/s12402-018-0271-z.

  24. Simonneaux, Ribelayga (2003): Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 2003 Jun;55(2):325-95. doi: 10.1124/pr.55.2.2. PMID: 12773631. REVIEW

  25. Palm, Uzoni, Simon, Fischer, Coogan, Tucha, Thome, Faltraco (2021): Evolutionary conservations, changes of circadian rhythms and their effect on circadian disturbances and therapeutic approaches. Neurosci Biobehav Rev. 2021 Jun 5;128:21-34. doi: 10.1016/j.neubiorev.2021.06.007. PMID: 34102148. REVIEW

  26. Zamore Z, Veasey SC (2022): Neural consequences of chronic sleep disruption. Trends Neurosci. 2022 Sep;45(9):678-691. doi: 10.1016/j.tins.2022.05.007. PMID: 35691776; PMCID: PMC9388586. REVIEW

  27. Lorton, Lubahn, Estus, Millar, Carter, Wood, Bellinger (2006): Bidirectional Communication between the Brain and the Immune System: Implications for Physiological Sleep and Disorders with Disrupted Sleep, Neuroimmunomodulation 2006;13:357–374, https://doi.org/10.1159/000104864

  28. Suarez (2008): Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun. 2008 Aug;22(6):960-8. doi: 10.1016/j.bbi.2008.01.011.

  29. Meier-Ewert, Ridker, Rifai, Regan, Price, Dinges, Mullington (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004 Feb 18;43(4):678-83. n = 20

  30. Vgontzas, Papanicolaou, Bixler, Lotsikas, Zachman, Kales, Prolo, Wong, Licinio, Gold, Hermida, Mastorakos, Chrousos (1999): Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999 Aug;84(8):2603-7.

  31. Vgontzas, Zoumakis, Bixler, Lin, Follett, Kales, Chrousos (2004): Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004 May;89(5):2119-26.

  32. Motivala, Sarfatti, Olmos, Irwin (2005): Inflammatory markers and sleep disturbance in major depression. Psychosom Med. 2005 Mar-Apr;67(2):187-94.

  33. Chrousos (2009): Stress and disorders of the stress system. Nat Rev Endocrinol. 2009 Jul;5(7):374-81. doi: 10.1038/nrendo.2009.106. PMID: 19488073. REVIEW

  34. Ehlers, Reed, Henriksen (1986): Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology. 1986;42(6):467-74. doi: 10.1159/000124489. PMID: 3084988.

  35. McGinty, Ronald (2000): Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 75

  36. West, Lookingland, Tucker (1997): Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation. Domest Anim Endocrinol. 1997 Sep;14(5):349-57. doi: 10.1016/s0739-7240(97)00031-3. PMID: 9347255.

  37. Steiger (2002): Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Med Rev. 2002 Apr;6(2):125-38.

  38. Gorgoni, Scarpelli, Reda, De Gennaro (2019): Sleep EEG oscillations in neurodevelopmental disorders without intellectual disabilities. Sleep Med Rev. 2019 Oct 30;49:101224. doi: 10.1016/j.smrv.2019.101224.

  39. Piao T, Wu G, Zhu Y, Zhong S, Dang C, Feng Y, Yang C, Wang Y, Wang C, Sun L (2025): Resting-state microstate dynamics abnormalities in children with ADHD and co-occurring sleep problems. Sleep Med. 2025 Apr;128:1-11. doi: 10.1016/j.sleep.2025.01.027. PMID: 39874815.

  40. Bestmann, Conzelmann, Baving, Prehn-Kristensen (2019): Associations between cognitive performance and sigma power during sleep in children with attention-deficit/hyperactivity disorder, healthy children, and healthy adults. PLoS One. 2019 Oct 24;14(10):e0224166. doi: 10.1371/journal.pone.0224166. eCollection 2019. n = 56

  41. Özbudak P, Özaslan A, Temel EÜ, Güney E, Serdaroğlu A, Arhan E. New Electrographic Marker? Evaluation of Sleep Spindles in Children with Attention Deficit Hyperactivity Disorder. Clin EEG Neurosci. 2022 Oct 19:15500594221134025. doi: 10.1177/15500594221134025. PMID: 36259661. n = 67

  42. Ueda, Takeichi, Kaga, Oguri, Saito, Nakagawa, Maegaki, Inagaki (2019): Atypical gamma functional connectivity pattern during light sleep in children with attention deficit hyperactivity disorder. Brain Dev. 2019 Nov 21. pii: S0387-7604(19)30510-8. doi: 10.1016/j.braindev.2019.11.001.

  43. Furrer, Jaramillo, Volk, Ringli, Aellen, Wehrle, Pugin, Kurth, Brandeis, Schmid, Jenni, Huber (2019): Sleep EEG slow-wave activity in medicated and unmedicated children and adolescents with attention-deficit/hyperactivity disorder. Transl Psychiatry. 2019 Nov 28;9(1):324. doi: 10.1038/s41398-019-0659-3. n = 136

  44. Mishra, Pullum, Thayer, Plummer, Conkright, Morris, O’Hara, Demas, Ashley (2020): Chemical sympathectomy reduces peripheral inflammatory responses to acute and chronic sleep fragmentation. Am J Physiol Regul Integr Comp Physiol. 2020 Mar 4. doi: 10.1152/ajpregu.00358.2019. PMID: 32130024.